Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Norwegian SARS-CoV-2 Study - Virological, Clinical and Immunological Characterisation of Inpatients During the COVID-19 Outbreak: A Prospective Cohort Study

NCT04381819 is registered in ClinicalTrials.gov with Oslo University Hospital as lead sponsor.

NCT NCT04381819
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04381819 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Norwegian SARS-CoV-2 Study - Virological, Clinical and Immunological Characterisation of Inpatients During the COVID-19 Outbreak: A Prospective Cohort Study
Lead sponsor
Oslo University Hospital
Phase
Observational
Overall status
Unknown status
Start date
March 2, 2020
Completion date
December 31, 2023
Enrollment
1,000 (estimated)
Sites
7

Conditions

As the registry lists them; a condition with its own page is linked.

sars virus, severe acute respiratory syndrome